Patent search cpc:"A61P25/16" Page 1

1.

发明公开
HETEROCYCLIC COMPOUNDS AND USES THEREOF 审中-公开

公开(公告)号：EP4436968A1

公开(公告)日：2024-10-02

申请号：EP22843901.4

申请日：2022-11-07

Applicant: Ventus Therapeutics U.S., Inc.

Inventor： BEVERIDGE, Ramsay , BURCH, Jason , FADER, Lee , BOILY, Marc-Olivier , ST-ONGE, Miguel , DORICH, Stéphane , CHAGNON, Felix , DURET, Guillaume

IPC: C07D417/12 , C07D417/14 , C07D471/04 , C07D487/04 , C07D498/04 , C07D513/04 , A61P3/00 , A61P9/00 , A61P11/00 , A61P13/12 , A61P17/00 , A61P25/00 , A61P25/16 , A61P25/28 , A61P27/02 , A61P29/00 , A61P31/00 , A61P37/00

CPC classification number: C07D417/12 , C07D417/14 , C07D498/04 , C07D513/04 , C07D487/04 , C07D471/04 , A61P35/00 , A61P29/00 , A61P37/00 , A61P31/00 , A61P25/00 , A61P3/00 , A61P9/00 , A61P11/00 , A61P13/12 , A61P27/02 , A61P17/00 , A61P25/16 , A61P25/28

2.

发明公开
BACTERIOTHERAPY 审中-公开

公开(公告)号：EP4417261A3

公开(公告)日：2024-10-02

申请号：EP24168584.1

申请日：2017-04-19

Applicant: Genome Research Limited

Inventor： NEVILLE, Anne , BROWNE, Hilary , FORSTER, Sam , LAWLEY, Trevor

IPC: A61K35/742 , A61P31/04

CPC classification number: A61K35/742 , A61P1/00 , A61P1/04 , A61P1/16 , A61P11/06 , A61P19/02 , A61P25/00 , A61P25/16 , A61P25/28 , A61P3/00 , A61P3/04 , A61P31/04 , A61P35/00 , A61P3/06 , A61P37/02 , A61P37/08 , A61P43/00 , A61P7/00 , A61P9/00 , A61P3/10 , Y02A50/30

Abstract: The invention relates to therapeutic compositions comprising at least one isolated bacterium and a pharmaceutically acceptable excipient, as well as methods of preparing such therapeutic compositions. The therapeutic compositions find application in the treatment of dysbiosis, in particular dysbiosis of the gastrointestinal tract.

3.

发明授权
AMPRELOXETINE FOR USE IN THE TREATMENT OF NEUROGENIC ORTHOSTATIC HYPOTENSION 有权

公开(公告)号：EP3506900B1

公开(公告)日：2024-10-02

申请号：EP17761725.5

申请日：2017-08-24

IPC: A61K31/4465 , A61K45/06 , A61P9/02 , A61K31/165 , A61K31/192 , A61K31/44 , A61K31/573 , A61P1/08

CPC classification number: A61K45/06 , A61K31/165 , A61K31/573 , A61K31/198 , A61K31/4425 , A61K31/4465 , C07D211/22 , A61P1/08 , A61P25/00 , A61P25/16 , A61P43/00 , A61P9/02

4.

发明公开
PYRIDAZINE DERIVATIVES AS INHIBITORS OF NLRP3 审中-实审

公开(公告)号：EP4433459A1

公开(公告)日：2024-09-25

申请号：EP22818338.0

申请日：2022-11-17

Applicant: F. Hoffmann-La Roche AG

Inventor： AITKEN, Lewis Scott , ALANINE, Thomas Alexander , BOUCHE, Lea Aurelie , GUBA, Wolfgang , JAESCHKE, Georg , MESCH, Stefanie Katharina , THOM, Stephen Malcom , TOSSTORFF, Andreas Michael , SCHNIDER, Christian , STEINER, Sandra , HERR, Sabrina

IPC: C07D237/24 , C07D401/12 , C07D471/04 , A61K9/20 , A61K9/48 , A61P11/00 , A61P11/06 , A61P25/16 , A61P25/28 , A61K31/501

CPC classification number: C07D237/24 , C07D401/12 , C07D471/04 , A61P11/00 , A61P11/06 , A61P25/16 , A61P25/28 , A61K9/2054 , A61K9/2059 , A61K9/4866

5.

发明公开
COMPOSITIONS AND SYSTEMS COMPRISING TRANSFECTION-COMPETENT VESICLES FREE OF ORGANIC-SOLVENTS AND DETERGENTS AND METHODS RELATED THERETO 审中-实审

公开(公告)号：EP4379053A3

公开(公告)日：2024-09-18

申请号：EP24156927.6

申请日：2019-10-09

Applicant: The University of British Columbia

Inventor： KULKARNI, Jayesh , HILL, Austin , CULLIS, Pieter , LEAVITT, Blair , PETKAU, Terri , WAGNER, Pamela

IPC: C12N15/88 , C12N9/22 , C12N15/113 , A61K9/50 , A61K47/12 , A61K47/14 , A61P25/16 , A61P25/28 , A61K9/00 , A61K9/127 , C12N15/11

CPC classification number: A61P25/28 , A61P25/16 , C12N15/113 , C12N15/88 , C12N2310/2020170501 , C12N15/111 , C12N2310/1420130101 , A61K9/1272 , A61K9/0019

Abstract: Lipid-based vesicles, typically herein called transfection competent vesicles (TCVs), configured to safely and efficiently deliver DNA, RNA, other nucleic acid and protein cargoes into target cells. The safety and efficiency are each, and both, achieved in part by eliminating organic solvents such as ethanol and detergents such as sodium dodecyl sulfate from the TCV loading processes (i.e., inserting a cargo into the TCV), TCV storage processes, and/or TCV delivery processes. The cargoes can also comprise nucleic acids complexed with a protein, such as a ribonucleoprotein (RNP). The systems, compositions, devices and methods, etc., herein, in some embodiments, can provide empty TCVs that can if desired be loaded at the bench without use of specialized equipment.

6.

发明公开
DOSING PROTOCOLS AND REGIMENS FOR AMINOSTEROL TREATMENT 审中-实审

公开(公告)号：EP4427738A2

公开(公告)日：2024-09-11

申请号：EP24191543.8

申请日：2020-07-31

Applicant: Enterin, Inc.

Inventor： BARBUT, Denise , ZASLOFF, Michael

IPC: A61K9/00

CPC classification number: A61K31/575 , A61P17/02 , A61K9/0014 , A61P25/16 , A61P1/10 , A61K9/006 , A61K47/10 , A61K9/08 , Y02A50/30

Abstract: The present application relates generally to a method of treating a cutaneous or mucosal wound in a subject in need comprising topically administering to the wound site a therapeutically effective amount of a topical pharmaceutical composition comprising at least one aminosterol or a salt or derivative thereof. Also provided are methods for treating, preventing, and/or slowing the onset or progression of a disease or condition, or a symptom thereof, amenable to treatment with an aminosterol or a salt or derivative thereof in a subject in need, comprising administering to the subject a therapeutically effective amount of at least one aminosterol or a salt or derivative thereof, wherein the subject is not lying down.